Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Preliminary findings suggest that this higher dosage may enhance the drug's ability to control blood glucose, potentially offering greater outcomes for individuals with diabetes. Further investigation is underway to fully evaluate the lo